Christian Confavreux
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohort.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: June 08, 2016
Geographical Heterogeneity of Multiple Sclerosis Prevalence in France.
Journal: PloS one
Published: January 11, 2016
History of multiple sclerosis in 2 successive pregnancies: A French and Italian cohort.
Journal: Neurology
Published: December 29, 2015
Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.
Journal: PloS one
Published: March 20, 2015
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 29, 2014
Multiple sclerosis registries in Europe - results of a systematic survey.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 30, 2014
Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions.
Journal: Glia
Published: February 12, 2014
The clinical course of multiple sclerosis.
Journal: Handbook of clinical neurology
Published: February 11, 2014
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Neurology
Published: January 28, 2014
One can prevent post-partum MS relapses by exclusive breast feeding: no.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 18, 2013
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 16, 2013
Last Updated: 09/26/2026